EU Scrutinizes J&J, Novartis Generic Painkiller Deals
The European Commission has begun examining whether agreements between Johnson & Johnson and Novartis AG's generics units have kept cheaper versions of a powerful painkiller off the Dutch market, the antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article